Literature DB >> 23911772

Histopathologic characterization of lung adenocarcinoma in relation to fluorine-18-fluorodeoxyglucose uptake on positron emission tomography.

Hiromitsu Domen1, Yasuhiro Hida, Shozo Okamoto, Kanako C Hatanaka, Yutaka Hatanaka, Kichizo Kaga, Nagara Tamaki, Satoshi Hirano, Yoshihiro Matsuno.   

Abstract

BACKGROUND: Fluorine-18-fluorodeoxyglucose uptake on positron emission tomography is reported to have prognostic significance in patients after resection of lung adenocarcinoma. However, its relationship with histopathologic features remains unknown.
METHODS: We conducted a retrospective analysis of 205 patients who had undergone surgical resection of primary lung adenocarcinoma (> 1.0 cm) after preoperative fluorine-18-fluorodeoxyglucose-positron emission tomography between January 1999 and December 2008 at Hokkaido University Hospital. Fluorine-18-fluorodeoxyglucose uptake was measured by the maximum standardized uptake value. A histopathologic review was performed according to the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, and various histopathologic factors were evaluated semi-quantitatively. Correlations between these clinicopathologic factors and the maximum standardized uptake value (high ≥ 2.0 vs low < 2.0) were analyzed.
RESULTS: Univariate analysis of clinicopathologic factors demonstrated that the following were significantly correlated with a high maximum standardized uptake value: an elevated carcinoembryonic antigen level, larger tumor size, upgraded pT, pN, pStage, non-lepidic histology, abundant fibroblastic/hyalinized stroma, necrosis, presence of pleural involvement, lymphatic and vascular invasion and more intra- and extracellular mucin. Multivariate analysis demonstrated that a tumor size of > 2.0 cm, non-lepidic histology and abundant fibroblastic/hyalinized stroma were significantly correlated with the high maximum standardized uptake value.
CONCLUSION: More histopathologic factors are known to correlate with poor prognosis in lung adenocarcinomas showing high maximum standardized uptake values than in those showing low maximum standardized uptake values. Therefore, prognostication of patients with a resectable lung adenocarcinoma on the basis of preoperative fluorine-18-fluorodeoxyglucose uptake is histopathologically valid. Such observations may also help us to clarify the pathobiological mechanism responsible for the increased fluorine-18-fluorodeoxyglucose uptake in lung adenocarcinomas with a poor prognosis.

Entities:  

Keywords:  fluorine-19-fluorodeoxyglucose; histopathology; lung adenocarcinoma; maximum standardized uptake value; positron emission tomography

Mesh:

Substances:

Year:  2013        PMID: 23911772     DOI: 10.1093/jjco/hyt100

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  4 in total

Review 1.  Advances in lung adenocarcinoma classification: a summary of the new international multidisciplinary classification system (IASLC/ATS/ERS).

Authors:  Elizabeth R Tang; Andrew M Schreiner; Bradley B Pua
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Interstitial lung disease pattern turned out to be a predominantly lepidic lung adenocarcinoma.

Authors:  Irena Hammen
Journal:  Respir Med Case Rep       Date:  2017-03-28

3.  Looking for Lepidic Component inside Invasive Adenocarcinomas Appearing as CT Solid Solitary Pulmonary Nodules (SPNs): CT Morpho-Densitometric Features and 18-FDG PET Findings.

Authors:  Alfonso Reginelli; Raffaella Capasso; Mario Petrillo; Claudia Rossi; Pierluigi Faella; Roberta Grassi; Maria Paola Belfiore; Giovanni Rossi; Maurizio Muto; Pietro Muto; Alfonso Fiorello; Nicola Serra; Rita Nizzoli; Massimo De Filippo; Salvatore Cappabianca; Gianpaolo Carrafiello; Luca Brunese; Antonio Rotondo
Journal:  Biomed Res Int       Date:  2019-01-13       Impact factor: 3.411

4.  Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer.

Authors:  Hirofumi Morimoto; Yasuhiro Hida; Nako Maishi; Hiroshi Nishihara; Yutaka Hatanaka; Cong Li; Yoshihiro Matsuno; Toru Nakamura; Satoshi Hirano; Kyoko Hida
Journal:  Thorac Cancer       Date:  2021-03-11       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.